As the SRC-3/TRAF4/PI3K/AKT pathway plays a vital role in ovarian cancer development, the SRC-3/TRAF4 pathway may be a promising therapeutic target for ovarian cancer treatment. The gene discussed is NCOA3; the disease is ovarian carcinoma.